TrimRx's Blog

Zepbound improves metabolic markers linked to aging, but it’s not an anti-aging drug. Learn what tirzepatide does to inflammation, insulin resistance, and

Zepbound (tirzepatide) shows early cognitive benefits through metabolic improvement, insulin resistance reduction, and inflammation control—here’s what

Zepbound’s (tirzepatide) relationship to Alzheimer’s risk involves complex metabolic pathways — insulin resistance, inflammation, and neuroprotective

Zepbound has a 5-day half-life, clearing 99% from your system in 4-5 weeks. Here’s what that means for weight maintenance, side effects, and restarting.

Zepbound (tirzepatide) is not physically addictive, but stopping creates metabolic challenges. Here’s what recovery protocols look like in 2026.

Zepbound isn’t FDA-approved for smoking cessation, but emerging research shows GLP-1 receptor agonists may reduce nicotine cravings through dopamine

Zepbound (tirzepatide) shows emerging evidence for reducing alcohol cravings through GLP-1 receptor pathways—here’s what patients need to know.

Zepbound (tirzepatide) shows potential neuroprotective effects in early research, but no established Parkinson’s risk or prevention mechanism has been

Zepbound doesn’t cause gambling addiction, but dual GIP/GLP-1 agonism affects dopamine pathways—here’s what patients taking tirzepatide need to know.